SCHEMBL4780897

SCHEMBL4780897

COC(=O)c1ccc(NC(=S)NC2CCN(c3nccc4ccccc34)CC2)cc1.COc1cccc(NC(=S)NC2CCN(c3nccc4ccccc34)CC2)c1.S=C(Nc1cccc(Br)c1)NC1CCN(c2nccc3ccccc23)CC1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MALT1 Q9UDY8 1/20 0.47
KMT2A Q03164 4/20 0.44
MEN1 O00255 3/20 0.44
ALDH1A1 P00352 2/20 0.44
MAPT P10636 1/20 0.44
DRD2 P14416 2/20 0.44
DRD4 P21917 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
CCNC P24863 1/20 0.43
CDK8 P49336 1/20 0.43
KDM4E B2RXH2 2/20 0.42
HTR1A P08908 1/20 0.41
HTR2A P28223 1/20 0.41
RAB9A P51151 1/20 0.41
TP53 P04637 1/20 0.41
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4583335 0.88 MEN1 (0.55) MALT1KMT2AMEN1ALDH1A1MAPT
SCHEMBL4583601 0.88 KMT2A (0.52) MALT1KMT2AMEN1ALDH1A1MAPT
SCHEMBL4582961 0.85 MALT1 (0.51) MALT1KMT2AMEN1DRD2DRD4
SCHEMBL4581567 0.85 MALT1 (0.45) MALT1KMT2AMEN1ALDH1A1KDM4E
SCHEMBL4725020 0.85 MAPT (0.44) KMT2AMEN1ALDH1A1MAPTCYP1A2
SCHEMBL4779982 0.83 ALDH1A1 (0.44) KMT2AMEN1ALDH1A1MAPTCYP1A2
SCHEMBL4729793 0.83 MALT1 (0.40) MALT1KMT2AMEN1ALDH1A1MAPT
SCHEMBL4583157 0.82 MALT1 (0.51) MALT1ALDH1A1MAPT
SCHEMBL4726520 0.78 KMT2A (0.40) MALT1KMT2AALDH1A1
SCHEMBL4582822 0.78 ALDH1A1 (0.51) KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008028690-A1 1-(HET)ARYL-3-[HETARYL-PIPERIDIN-4-YL]-THIOUREAS AS MODULATORS OF THE EP2 RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-03-13 WO disclosed